- R&D
Overcoming Age-Related Challenges in Nanodrug Delivery for Pediatric Cancer Patients
The efficacy of medical treatments often varies with age, and this principle holds true in the world of nanodrug delivery for pediatric,...Promising BP-NELL-PEG compound may protect astronauts from rapid bone loss in space
After an unprecedented live return of mice from the International Space Station (ISS), the results were nothing short of astonishing. Soo, a...Boston Scientific’s Farapulse System Irregular Heartbeat Treatment
Boston Scientific, a pioneering force in medical technology, has revealed clinical data from a head-to-head trial that underscores the immense potential of...Two-Year Study Shows Nevro’s High-Frequency Neurostimulation Reduces Diabetic Neuropathy Pain by 80%
Nevro's high-frequency neurostimulation system, after being granted FDA approval as the pioneering spinal cord stimulator to alleviate diabetic neuropathy pain, has received...
- Clinical
Morphic’s EMERALD-1 trial for ulcerative colitis disappoints
Investors have raised a concern about Morphic's eagerly awaited EMERALD-1 trial. Despite experiencing an initial surge in stock values following the release...Ionis sees success in lipid reduction Phase 3 trial
Ionis Pharmaceuticals has achieved a significant milestone in their phase 3 clinical trial focused on therapies that reduce lipids. This achievement positions...Phase 3 trial data for Astellas’s GA drug yielded positive results
A mere six weeks after obtaining FDA approval, Astellas Pharma is already considering expanding the label for Izervay, an eye injection acquired...With the trial’s success, AbbVie prepares Botox for a different aesthetic use
Recently, AbbVie disclosed positive outcomes from a second phase 3 trial of Botox, aimed at managing moderate to severe platysma prominence. This...
- Manufacturing
Merck and Ginkgo Forge $490 Million Partnership to Enhance Biologics Manufacturing Efficiency
Merck has solidified a substantial collaboration valued at $490 million with Ginkgo Bioworks, aimed at revolutionizing the landscape of biologics manufacturing. This...Vertex and Lonza Join Forces to Open New Manufacturing Facility for the Former’s T1D Therapies
Vertex Pharmaceuticals and Lonza have announced a strategic partnership to construct a new joint manufacturing facility in Portsmouth, New Hampshire. The primary...Pfizer to Stop Development of Oral Obesity Drug Amidst Liver Safety Concerns
Pfizer is set to discontinue one of its oral obesity drugs - namely lotiglipron - after observing higher levels of liver enzymes...Novartis Secures $3.2 Billion Acquisition of Chinook to Enhance Kidney Disease Strategy
Novartis, the Swiss pharmaceutical giant, is set to bolster its kidney disease pipeline through the acquisition of Chinook Therapeutics for an impressive...
- Commercial
CGM-connected app feature for Type 2 diabetes patients, unveiled by Abbott and WeightWatchers
One year after allying with the shared objective of enhancing health management for individuals diagnosed with Type 2 diabetes, Abbott and WeightWatchers...Fresh Tracks Set to Dissolve with no Buyer in the Pipeline
After months of looking into various other possibilities, Fresh Tracks Therapeutics has decided to dissolve its operations, as the board of directors...Sanofi divests 11 CNS medications to Pharmanovia in a strategic slimming-down move
In a strategic maneuver aimed at streamlining its product portfolio, pharmaceutical juggernaut Sanofi has initiated the sale of 11 central nervous system...
- Technology
Trialbee’s new tool aims to expedite clinical trial recruitment delays
Clinical trials play a pivotal role in advancing medical research and the development of innovative treatments. However, one major hurdle that often...Revvity introduces advanced preclinical imaging tech for scientists to make breakthroughs
Revvity, Inc. is ushering in a new era of innovation in the realm of preclinical research by introducing an advanced imaging portfolio...GE HealthCare introduces Vscan Air SL: a handheld ultrasound device for rapid cardiovascular assessment
GE Healthcare has unveiled its latest innovation: the Vscan Air SL handheld ultrasound device. This pioneering addition to the Vscan line promises...Living fillings: the future of regenerative dentistry?
While dental technology has advanced significantly over the years, the ability to regrow lost teeth has remained elusive. However, a groundbreaking study...
- Regulatory
60 Degrees Pharmaceuticals Halts Tafenoquine COVID-19 Trial in Response to FDA Recommendations
In accordance with FDA guidance, 60 Degrees Pharmaceuticals has opted to halt the Phase IIb trial for tafenoquine, known as ACLR8-LR. This...UCB’s Psoriasis Drug Application Faces a Further FDA Delay
In May of this year, the FDA issued a full response letter that delayed the launch of UCB's bimekizumab treatment for psoriasis...FDA Gives Green Light to GSK’s Innovative Bone Cancer Drug, Validating Billion-Dollar Investment
The Food and Drug Administration (FDA) has granted approval for GSK's groundbreaking treatment for myelofibrosis, a form of bone marrow cancer, signifying...FDA Issues Warning to 8 Companies Selling Illegal Eye Drugs
The Food and Drug Administration (FDA) said on Tuesday that it is taking action against eight different firms because it believes they...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
- R&D
Overcoming Age-Related Challenges in Nanodrug Delivery for Pediatric Cancer Patients
The efficacy of medical treatments often varies with age, and this principle holds true in the world of nanodrug delivery for pediatric,...Promising BP-NELL-PEG compound may protect astronauts from rapid bone loss in space
After an unprecedented live return of mice from the International Space Station (ISS), the results were nothing short of astonishing. Soo, a...Boston Scientific’s Farapulse System Irregular Heartbeat Treatment
Boston Scientific, a pioneering force in medical technology, has revealed clinical data from a head-to-head trial that underscores the immense potential of...Two-Year Study Shows Nevro’s High-Frequency Neurostimulation Reduces Diabetic Neuropathy Pain by 80%
Nevro's high-frequency neurostimulation system, after being granted FDA approval as the pioneering spinal cord stimulator to alleviate diabetic neuropathy pain, has received...
- Clinical
Morphic’s EMERALD-1 trial for ulcerative colitis disappoints
Investors have raised a concern about Morphic's eagerly awaited EMERALD-1 trial. Despite experiencing an initial surge in stock values following the release...Ionis sees success in lipid reduction Phase 3 trial
Ionis Pharmaceuticals has achieved a significant milestone in their phase 3 clinical trial focused on therapies that reduce lipids. This achievement positions...Phase 3 trial data for Astellas’s GA drug yielded positive results
A mere six weeks after obtaining FDA approval, Astellas Pharma is already considering expanding the label for Izervay, an eye injection acquired...With the trial’s success, AbbVie prepares Botox for a different aesthetic use
Recently, AbbVie disclosed positive outcomes from a second phase 3 trial of Botox, aimed at managing moderate to severe platysma prominence. This...
- Manufacturing
Merck and Ginkgo Forge $490 Million Partnership to Enhance Biologics Manufacturing Efficiency
Merck has solidified a substantial collaboration valued at $490 million with Ginkgo Bioworks, aimed at revolutionizing the landscape of biologics manufacturing. This...Vertex and Lonza Join Forces to Open New Manufacturing Facility for the Former’s T1D Therapies
Vertex Pharmaceuticals and Lonza have announced a strategic partnership to construct a new joint manufacturing facility in Portsmouth, New Hampshire. The primary...Pfizer to Stop Development of Oral Obesity Drug Amidst Liver Safety Concerns
Pfizer is set to discontinue one of its oral obesity drugs - namely lotiglipron - after observing higher levels of liver enzymes...Novartis Secures $3.2 Billion Acquisition of Chinook to Enhance Kidney Disease Strategy
Novartis, the Swiss pharmaceutical giant, is set to bolster its kidney disease pipeline through the acquisition of Chinook Therapeutics for an impressive...
- Commercial
CGM-connected app feature for Type 2 diabetes patients, unveiled by Abbott and WeightWatchers
One year after allying with the shared objective of enhancing health management for individuals diagnosed with Type 2 diabetes, Abbott and WeightWatchers...Fresh Tracks Set to Dissolve with no Buyer in the Pipeline
After months of looking into various other possibilities, Fresh Tracks Therapeutics has decided to dissolve its operations, as the board of directors...Sanofi divests 11 CNS medications to Pharmanovia in a strategic slimming-down move
In a strategic maneuver aimed at streamlining its product portfolio, pharmaceutical juggernaut Sanofi has initiated the sale of 11 central nervous system...
- Technology
Trialbee’s new tool aims to expedite clinical trial recruitment delays
Clinical trials play a pivotal role in advancing medical research and the development of innovative treatments. However, one major hurdle that often...Revvity introduces advanced preclinical imaging tech for scientists to make breakthroughs
Revvity, Inc. is ushering in a new era of innovation in the realm of preclinical research by introducing an advanced imaging portfolio...GE HealthCare introduces Vscan Air SL: a handheld ultrasound device for rapid cardiovascular assessment
GE Healthcare has unveiled its latest innovation: the Vscan Air SL handheld ultrasound device. This pioneering addition to the Vscan line promises...Living fillings: the future of regenerative dentistry?
While dental technology has advanced significantly over the years, the ability to regrow lost teeth has remained elusive. However, a groundbreaking study...
- Regulatory
60 Degrees Pharmaceuticals Halts Tafenoquine COVID-19 Trial in Response to FDA Recommendations
In accordance with FDA guidance, 60 Degrees Pharmaceuticals has opted to halt the Phase IIb trial for tafenoquine, known as ACLR8-LR. This...UCB’s Psoriasis Drug Application Faces a Further FDA Delay
In May of this year, the FDA issued a full response letter that delayed the launch of UCB's bimekizumab treatment for psoriasis...FDA Gives Green Light to GSK’s Innovative Bone Cancer Drug, Validating Billion-Dollar Investment
The Food and Drug Administration (FDA) has granted approval for GSK's groundbreaking treatment for myelofibrosis, a form of bone marrow cancer, signifying...FDA Issues Warning to 8 Companies Selling Illegal Eye Drugs
The Food and Drug Administration (FDA) said on Tuesday that it is taking action against eight different firms because it believes they...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
Editor Picks
Life Sciences Voice Top Five Newsletter
This week we take a look at FDA’s approval for a drug...
Life Sciences Voice Top Five Newsletter
This week we delve into the latest news in the pharma world...
Moderna unveils plans to develop vaccines for pathogens with pandemic potential
Pharmaceutical giant Moderna has revealed its plans for the development of vaccines...
Must Read
Morphic’s EMERALD-1 trial for ulcerative colitis disappoints
Investors have raised a concern about Morphic's eagerly awaited EMERALD-1 trial. Despite...
Ionis sees success in lipid reduction Phase 3 trial
Ionis Pharmaceuticals has achieved a significant milestone in their phase 3 clinical...
Overcoming Age-Related Challenges in Nanodrug Delivery for Pediatric Cancer Patients
The efficacy of medical treatments often varies with age, and this principle...
About Us
Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.
Contact us: reachout(at)lifescivoice.com